Top 10 Key Players companies in PCSK9 Inhibitors by Most Research Publications in the United States in 2020 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Research Publications PCSK9 Inhibitors Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	The Brigham & Women's Hospital, Inc.	Massachusetts, United States	Health care,Mitral valve surgery,Health equity, ...[+2]	Literature: 9
2	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Literature: 5
3	Cardiovascular Institute of the South	Louisiana, United States	Vascular Medicine,Health care,Lipid management, ...[+2]	Literature: 3
4	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Literature: 2
5	Beth Israel Deaconess Medical Center, Inc.	Massachusetts, United States	Medical school,Clinical research,Health care, ...[+2]	Literature: 2
6	Memorial Hospital & Health System	Indiana, United States	Health care,Hospitality industry,Childbirth, ...[+2]	Literature: 2
7	Houston Methodist St. Catherine Hospital	Texas, United States	Health care,Hospitality industry,Continuing care, ...[+2]	Literature: 2
8	Baptist Hospital of Miami, Inc.	United States	Physician self-referral,Health care,Hospitality industry, ...[+2]	Literature: 2
9	Merck & Co., Inc.	New Jersey, United States	Health care,Biopharmaceutical,Drug, ...[+2]	Literature: 1
10	Esperion Therapeutics, Inc.	Michigan, United States	Medicine,Health care,Cardiovascular agent, ...[+2]	Literature: 1